Multiple Sclerosis Relapses Following Cessation of Fingolimod

BACKGROUND: There is growing interest in the issue of disease reactivation in multiple sclerosis following fingolimod cessation. Relatively little is known about modifiers of the risk of post-cessation relapse, including the delay to commencement of new therapy and prior disease activity. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Malpas, Charles B., Roos, Izanne, Sharmin, Sifat, Buzzard, Katherine, Skibina, Olga, Butzkueven, Helmut, Kappos, Ludwig, Patti, Francesco, Alroughani, Raed, Horakova, Dana, Havrdova, Eva Kubala, Izquierdo, Guillermo, Eichau, Sara, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Kalincik, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989797/
https://www.ncbi.nlm.nih.gov/pubmed/35303292
http://dx.doi.org/10.1007/s40261-022-01129-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989797/
https://www.ncbi.nlm.nih.gov/pubmed/35303292
http://dx.doi.org/10.1007/s40261-022-01129-7

Ejemplares similares